(UroToday.com) As a portion of the European Society for Medical Oncology (ESMO) Annual Congress, an Educational Session focused on improving outcomes in bladder cancer was held. In this context, Dr. Cathomas discussed how to select the optimal first line systemic therapy in advanced urothelial disease.